Article citationsMore>>

P. Kolvunen, M. Hirsila, A. M. Remes, I. E. Hassinen, K. I. Kivirikko and J. Myllyharju, “Inhibition of Hypoxia-Inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates: Possible Links between Cell Metabolism and Stabilization of HIF,” The Journal of Biological Chemistry, Vol. 282, No. 7, 2007, pp. 4524-4532. doi:10.1074/jbc.M610415200

has been cited by the following article:

• TITLE: Mitochondrial Signaling in Hypoxia

  AUTHORS: Ludmila D. Lukyanova

  KEYWORDS: Respiratory Chain Reprogramming; Mitochondrial Complexes I and II; Adaptation to Hypoxia; Succinate; HIF-1; Energotropic Drugs; Antihypoxic Activity

  JOURNAL NAME: Open Journal of Endocrine and Metabolic Diseases, Vol.3 No.2A, May 20, 2013

  ABSTRACT: This paper focuses on a bioenergetic mechanism responding to hypoxia. This response involves hypoxia-induced reprogramming of respiratory chain function and switching from oxidation of complex I (NAD-related substrates) to complex II (succinate oxidation). Transient, reversible, compensatory activation of respiratory chain complex II is a major mechanism of urgent adaptation to hypoxia, which is necessary for 1) succinate-related energy synthesis in the conditions of oxygen shortage and formation of urgent resistance; 2) succinate-related stabilization of HIF-1α and initiation of its transcriptional activity related with formation of long-term adaptation; 3) succinate-dependent activation of the succinate-specific receptor GPR91. Thus, mitochondria perform a signaling function with succinate as a signaling molecule. Effects of succinate in hypoxia occur at three levels, intramitochondrial, intracellular and intercellular. In these settings, succinate displays antihypoxic activity. The review is focused on tactics and strategy for development of the antihypoxic defense and antihypoxants with energotropic properties.